PEAK6 Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$33.4M Buy
420,500
+353,800
+530% +$29.4M 0.14% 113
2018
Q1
$5.95M Sell
66,700
-33,300
-33% -$3.2M 0.03% 715
2017
Q4
$10.4M Sell
100,000
-526,500
-84% -$59.4M 0.05% 447
2017
Q3
$91.4M Sell
626,500
-995,100
-61% -$136M 0.47% 25
2017
Q2
$211M Buy
1,621,600
+1,488,300
+1,117% +$182M 1.22% 5
2017
Q1
$16.6M Sell
133,300
-117,300
-47% -$14M 0.14% 161
2016
Q4
$29M Sell
250,600
-154,100
-38% -$17.2M 0.21% 65
2016
Q3
$42.3M Buy
404,700
+234,500
+138% +$25.4M 0.31% 30
2016
Q2
$16.8M Sell
170,200
-130,100
-43% -$13.5M 0.13% 158
2016
Q1
$30.1M Sell
300,300
-148,000
-33% -$15.2M 0.24% 58
2015
Q4
$53.7M Sell
448,300
-118,700
-21% -$13.7M 0.36% 17
2015
Q3
$61.3M Sell
567,000
-13,800
-2% -$1.71M 0.32% 21
2015
Q2
$67.2M Buy
580,800
+149,600
+35% +$17.1M 0.4% 15
2015
Q1
$49.7M Buy
431,200
+161,400
+60% +$19.3M 0.38% 15
2014
Q4
$30.2M Buy
269,800
+79,900
+42% +$8.43M 0.23% 62
2014
Q3
$18M Sell
189,900
-220,500
-54% -$19.9M 0.14% 147
2014
Q2
$35.2M Buy
410,400
+315,400
+332% +$24M 0.34% 27
2014
Q1
$6.63M Sell
95,000
-161,800
-63% -$12.8M 0.06% 465
2013
Q4
$21.7M Sell
256,800
-733,600
-74% -$58M 0.15% 94
2013
Q3
$38.2M Buy
990,400
+646,400
+188% +$45.3M 0.26% 26
2013
Q2
$20.1K Buy
+344,000
New +$20.7M 0.08% 99

Other funds holding CELG

PEAK6 Group's CELG Position: Q2 2018 in Review

PEAK6 Group reduced its Celgene Corp (CELG) stake by 40% in Q2 2018, selling an estimated $6.04M and leaving 109,584 shares worth $8.7M. The position accounts for 0.04% of the portfolio, ranked #512.

PEAK6 Group first reported a position in CELG in Q4 2013 and has held it in 16 quarters since. The position peaked at $34M in Q2 2015. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • PEAK6 Group held 109,584 shares of Celgene Corp worth $8.7M as of Q2 2018.
  • PEAK6 Group sold 72,740 Celgene Corp shares in Q2 2018, an estimated $6.04M.
  • Celgene Corp made up 0.04% of PEAK6 Group's portfolio in Q2 2018, its #512 holding.
  • PEAK6 Group first reported a position in Celgene Corp in Q4 2013 and has held it in 16 quarters since.
  • PEAK6 Group's Celgene Corp position peaked at $34M in Q2 2015.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.